Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government

UK Government has secured supply of 60 million doses at a cost of €470 million with options over another 130 million doses between 2022 and 2025 UK Government invests in Valneva’s manufacturing facility in Livingston, Scotland, to support scale up, creating major UK vaccine facility Inactivated, adjuvanted, two-dose SARS-COV-2 vaccine candidate scheduled to enter first … Continue reading Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government